264 related articles for article (PubMed ID: 32116226)
1. [Intestinal microbiom modulates the response to antitumor immunotherapy].
Olekhnovich EI; Manolov AI; Pavlenko AV; Konanov DN; Fedorov DE; Tikhonova PO; Glushchenko OE; Ilina EN
Biomed Khim; 2020 Jan; 66(1):54-63. PubMed ID: 32116226
[TBL] [Abstract][Full Text] [Related]
2. Intestinal microbiota: A potential target for enhancing the antitumor efficacy and reducing the toxicity of immune checkpoint inhibitors.
Luo B; Zhang Y; Zhang C; Liu X; Shi C
Cancer Lett; 2021 Jul; 509():53-62. PubMed ID: 33845122
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
[TBL] [Abstract][Full Text] [Related]
4. Roles of intestinal microbiota in response to cancer immunotherapy.
Cong J; Zhang X
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2235-2240. PubMed ID: 30209679
[TBL] [Abstract][Full Text] [Related]
5. [The role of intestinal microbiota in tumor occurrence, development and immunotherapy: a review].
Deng H; Fan X
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2105-2119. PubMed ID: 35786465
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
7. Advances in research on the relationship between the gut microbiome and cancer.
Song P; Wang QB; Liang B; Jiang SJ
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5104-5112. PubMed ID: 34486684
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome and cancer immunotherapy.
Li W; Deng Y; Chu Q; Zhang P
Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
[TBL] [Abstract][Full Text] [Related]
9. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
10. The impact of the intestinal microbiota in therapeutic responses against cancer.
Goubet AG; Daillère R; Routy B; Derosa L; M Roberti P; Zitvogel L
C R Biol; 2018; 341(5):284-289. PubMed ID: 29631891
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cancer immunotherapy efficacy by gut microbiota.
Huo S; Liu L; Liu J; Li Q; Wang J
Discov Med; 2019 Feb; 27(147):93-100. PubMed ID: 30939293
[TBL] [Abstract][Full Text] [Related]
12. Intestinal microbiota: a new force in cancer immunotherapy.
Dai Z; Zhang J; Wu Q; Fang H; Shi C; Li Z; Lin C; Tang D; Wang D
Cell Commun Signal; 2020 Jun; 18(1):90. PubMed ID: 32522267
[TBL] [Abstract][Full Text] [Related]
13. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota.
Dong M; Meng Z; Kuerban K; Qi F; Liu J; Wei Y; Wang Q; Jiang S; Feng M; Ye L
Cell Death Dis; 2018 Oct; 9(10):1039. PubMed ID: 30305604
[TBL] [Abstract][Full Text] [Related]
14. Microbiome and cancer immunotherapy.
Chilakapati SR; Ricciuti J; Zsiros E
Curr Opin Biotechnol; 2020 Oct; 65():114-117. PubMed ID: 32192986
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
[TBL] [Abstract][Full Text] [Related]
16. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
[TBL] [Abstract][Full Text] [Related]
17. Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light.
Zhang J; Wu K; Shi C; Li G
Curr Treat Options Oncol; 2022 Dec; 23(12):1777-1792. PubMed ID: 36279081
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.
Guven DC; Aktas BY; Simsek C; Aksoy S
Future Oncol; 2020 Mar; 16(9):497-506. PubMed ID: 32100550
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of the gut microbiota in cancer immunotherapy.
Shi Z; Li H; Song W; Zhou Z; Li Z; Zhang M
Front Immunol; 2023; 14():1139821. PubMed ID: 36911704
[TBL] [Abstract][Full Text] [Related]
20. Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Derosa L; Routy B; Desilets A; Daillère R; Terrisse S; Kroemer G; Zitvogel L
Cancer Discov; 2021 Oct; 11(10):2396-2412. PubMed ID: 34400407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
